Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese Volunteers

Human Immunodeficiency Virus (HIV) Infection Clinical Trial

Official title:
An Open Label Single Dose Study To Investigate Safety And Pharmacokinetics Of Maraviroc Following A Single Oral Dose Of 300 Mg Maraviroc (Two 150 Mg Maraviroc Commercial Tablets) Under Fasting Conditions In Healthy Male Japanese Volunteers

Status Completed

Clinical Trial Summary

To confirm safety and pharmacokinetics of maraviroc following a single oral dose of 300 mg maraviroc in healthy male Japanese volunteers.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label

Related Conditions & MeSH terms

Acquired Immunodeficiency Syndrome
HIV Infections
Human Immunodeficiency Virus (HIV) Infection
Immunologic Deficiency Syndromes

Clinical Trial Details

NCT number	NCT00821535
Study type	Interventional
Source	ViiV Healthcare
Contact
Status	Completed
Phase	Phase 1
Start date	February 2009
Completion date	May 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02715700` - Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045)	Phase 1
Completed	`NCT03667547` - Safety, Tolerability, and Pharmacokinetics of Raltegravir (MK-0518) in Healthy Japanese Male Participants (MK-0518-851)	Phase 4
Completed	`NCT01422330` - A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients	Phase 4
Active, not recruiting	`NCT05452616` - Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of Tuberculosis	N/A
Completed	`NCT04515641` - Single-Dose Islatravir in Moderate Hepatic Impairment (MK-8591-030)	Phase 1
Terminated	`NCT02818283` - Soy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary Intervention	N/A
Completed	`NCT04303156` - Pharmacokinetics of Islatravir in Participants With Severe Renal Impairment (MK-8591-026)	Phase 1
Completed	`NCT00717067` - Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function	Phase 4
Recruiting	`NCT04375800` - Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Ages 4 Weeks to <12 Years and <45 kg (MK-1439-066)	Phase 2
Completed	`NCT03618511` - Interventions to Improve HIV Antiretroviral Therapy Adherence	N/A
Completed	`NCT01768182` - Folinic Acid and Vascular Reactivity in HIV	N/A